Cost-effectiveness of quetiapine with lithium or divalproex for maintenance treatment of bipolar I disorder.

@article{Woodward2009CosteffectivenessOQ,
  title={Cost-effectiveness of quetiapine with lithium or divalproex for maintenance treatment of bipolar I disorder.},
  author={Tatia Chay Woodward and Eskinder Tafesse and Peter L. Quon and Jennifer M Kim and Arthur Lazarus},
  journal={Journal of medical economics},
  year={2009},
  volume={12 4},
  pages={259-68}
}
BACKGROUND Bipolar I disorder is a recurrent illness that affects 1% of the US population and constitutes a large economic burden. Few studies have investigated the cost-effectiveness of maintenance treatment options. The objective of this analysis was to assess the cost-effectiveness of quetiapine (QTP) in combination with lithium (Li) or divalproex (DVP) compared with that of Li or DVP alone for maintenance treatment of bipolar disorder. METHODS The cost-effectiveness of maintenance… CONTINUE READING